Vantaa, Finland

Katja Valimaki

USPTO Granted Patents = 9 

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 54(Granted Patents)


Company Filing History:


Years Active: 2014-2022

Loading Chart...
9 patents (USPTO):Explore Patents

Title: **Katja Valimaki: Innovator in Pharmaceutical Sciences**

Introduction

Katja Valimaki, based in Vantaa, Finland, is a distinguished inventor with a remarkable portfolio of nine patents. Her innovative contributions primarily focus on the realm of pharmaceuticals, particularly in the development of modified beta-lactamases. Through her work, she has significantly advanced the understanding and application of these essential enzymes in medicine.

Latest Patents

One of Katja's latest patents, titled "Modified beta-lactamases and methods and uses related thereto," addresses critical advancements in pharmaceuticals. This invention relates to novel recombinant beta-lactamases and pharmaceutical compositions that utilize these enzymes. The patent outlines methods for modifying beta-lactamases and producing them, emphasizing treatment and prevention of adverse effects induced by beta-lactam antibiotics. Additionally, her work includes the development of beta-lactamases for use as medicaments, along with the creation of polynucleotides and host cells comprising these polynucleotides.

Career Highlights

Throughout her career, Katja Valimaki has made substantial contributions to pharmaceutical research and development. She has worked with notable companies, including Synthetic Biologics, Inc. and Synthetic Biologies, Inc., leveraging her expertise in biotechnology and enzyme engineering. Her innovative approach has led to the development of new therapeutic solutions that improve the safety and efficacy of antibiotic treatments.

Collaborations

Katja has collaborated with several prominent professionals in her field, including her coworkers Pertti Koski and Ulla Airaksinen. These collaborations have enriched her research, fostering a multidisciplinary approach to addressing complex challenges in pharmaceutical sciences.

Conclusion

Katja Valimaki represents a significant force in the innovation of pharmaceuticals, with her extensive work on beta-lactamases paving the way for new medical treatments. Her dedication and inventive spirit continue to inspire advancements in the field, showcasing the vital role of inventors in enhancing global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…